A Clinical Trial of XZP-6019 Tablets in Healthy Subjects
Status:
Not yet recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
This study will consist of 3 parts: Part A - Single Ascending Dose (SAD) phase, Part B - Food
Effect (FE) phase, and Part C - multiple ascending dose (MAD) phase.